Dec. 23, 2021 — The FDA has granted emergency use authorization to Merck’s antiviral drug to treat adults with mild to moderate COVID-19 who are at risk for severe disease. Similar to FDA authorization of another antiviral pill regimen — ritonavir plus nirmatrelvir, or Paxlovid — granted to Pfizer on Wednesday, molnupiravir (brand name Lagevrio) …
Continue reading “FDA OKs Emergency Use of Merck Pill for COVID-19”